SYRS - Syros Pharmaceuticals Inc. (SYRS) CEO Nancy Simonian on Q3 2021 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS) Q3 2021 Earnings Conference Call November 5, 2021 8:30 AM ET Company Participants Courtney Solberg - Manager, Corporate Communications Nancy Simonian - President and Chief Executive Officer Jason Haas - Chief Financial Officer David Roth - Chief Medical Officer Kristin Stephens - Chief Development Office Eric Olson - Chief Scientific Officer Conference Call Participants Ted Tenthoff - Piper Jaffray Phil Nadeau - Cowen and Company Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Zegbeh Jallah - Roth Capital Partners Presentation Operator Good day and thank you for standing by. Welcome to Q3, 2021 Syros Pharmaceuticals Inc Earnings Conference call. [Operator instructions] Please be advised that today's conference is being recorded. I'd like to hand the conference over to your speaker today, Courtney Solberg with Syros. Please go ahead. Courtney Solberg Thank you. This morning, we issued a press release with our third quarter 2019 financial
For further details see:
Syros Pharmaceuticals, Inc. (SYRS) CEO Nancy Simonian on Q3 2021 Results - Earnings Call Transcript